Introduction
In many nations, such as the United States, Marijuana is the most widely used illegal substance. Approximately 28 million years ago, on the eastern Tibetan Plateau, the cannabis plant underwent evolution, as revealed by a pollen study released in May 2019. According to the survey, it has been used for as long as 2500 years (Marcu 289). Numerous studies have found Marijuana to have a variety of advantages. They include both medical and recreational. Marijuana, also widely recognized as cannabis or hemp, is currently illegal in 35 states. Only 15 states have legalized Marijuana (Hall 281). Whether Marijuana should be legalized is a contentious issue. It is essential to comprehend which assertions relate to the public and how such discussions to influence policy positions. This understanding is crucial for public medical and health stakeholders who will have to communicate new research results about the economic, health, and social implications of legalizing recreational Marijuana in the coming years. It is essential to comprehend which assertions relate to the public and how such discussions to influence policy positions. This paper argues in favor of legalizing Marijuana, emphasizing the array of CBD oils and products that have extensive benefits to society.
Americans are exposed to arguments supporting and against decriminalizing cannabis for adult recreational consumption through mainstream media and other sources. Numerous arguments are defined concerning the possible effects of the policy, as is typical in discussions of social policy. According to communication research, audiences can be persuaded to endorse the public policy. This is achieved by emphasizing particular elements of an issue and framing it in a particular way (McGinty et al. 85). Little is generally recognized about how the general public views the relative merits of contending arguments for and against the decriminalization of Marijuana for recreational use. Also of importance is how strongly different assertions are linked to backing decriminalization. Public medical and health experts will have to communicate new research findings concerning the economic, health, and social implications of legalizing recreational Marijuana over the coming decades (McGinty et al. 85). It is essential to comprehend which suppositions gain traction with the public and how such assertions influence policy choices.
The vast and varied discipline of integrative medicine has become more prominent. This progress is because there is growing enthusiasm for discovering more ways to treat people experiencing pain. Also, there is some proof that the availability of medicinal Marijuana is associated with a decline in opioid usage. The use of the Cannabis sativa plant in medical Marijuana, cannabidiol (CBD) oils, and hemp has emerged as a potential area. However, there has been debate over the benefits and risks of promoting poorly managed medical use of a drug understood to be addictive (VanDolah 1840). Due to the relatively low tetrahydrocannabinol (THC) content, hemp and cannabidiol oils have gained prominence since they are thought to have health benefits without the psychoactive effects of Marijuana.
CBD Oils and their Health Relevance in Body Systems
The legalization of Marijuana, mainly for CBD and hemp oils, will revolutionize the field of medicine in many ways. Many human systems involve hormones or compounds with the same molecular structure as that CBD elements. It is essential to consider the benefits of CBD oils in improved healthcare before quickly discarding the idea of legalizing any Marijuana products. By linking all of the body’s organs and structures, the endocannabinoid system plays a crucial role in maintaining homeostasis throughout the entire organism. The ECS has been linked to several pathological conditions and crucial regulatory processes. They include the maintenance of cellular immune metabolism in the gut, anxiety, chronic inflammatory conditions, and migraines (VanDolah 1840). Phytocannabinoids, cannabinoids derived from plants, have been looked into as possible therapeutic options in several cases. This consideration has been mainly due to their modulation of the ECS. Such a solution emerges even though the body already produces its intracellular cannabinoids, most prominently 2-arachidonylglycerol and anandamide.
The body has a complex ECS that functions through intracellular cannabinoids. Nevertheless, many cannabinoids derived from plants have additionally been found to function on the ECS. Over 80 phytocannabinoid derivatives were found in the marijuana plant (VanDolah 1841). The initial discoveries were made based on C sativa research. It would be unfair to criminalize Marijuana without considering such huge discoveries. Discoveries can be applied to ensure that patients get better medicinal and therapeutic services. Many other foods and plants, including carrots, black pepper, cloves, Echinacea, and ginseng, have also been found to contain phytocannabinoids and other significant C sativa constituents as terpenoids (VanDolah 1845). CBD and THC, the far more prevalent phytocannabinoids in cannabis and hemp strains, are the most well-understood and remarkable.
Tetrahydrocannabinol has been shown to act as an agonist at the CB1 receptor primarily. This process results in its very well-understood intoxicating impacts. Contrarily, it has been discovered that cannabidiol works through a diverse array of intricate pharmacological processes (VanDolah 1847). These processes include the suppression of endocannabinoid reuptake, activation of G protein-coupled receptor 55 and transient receptor possible vanilloid 1, and increased frequency of serotonin 5-HT1A receptors (VanDolah 1847). Cannabidiol has significantly less psychoactivity than THC because of how little it agitates the CB receptors. Therefore, it is essential to consider the therapeutic and health benefits that CBD and hemp oils provide to the human system, even without the THC compound, which results in highness and substance abuse.
CBD Oils as a Painkiller
Chronic pain is a condition associated with many patients experiencing a variety of illnesses. For instance, cancer patients and patients with inflammatory guts experience immense pain (Marcu 291). Regular painkillers may be working for these patients. However, there is a high likelihood that such patients end up getting addicted to strong painkillers such as oxycodone. The remedy for severe pain may be aided by hemp and CBD oils. In neuropathic and inflammatory rodent pain frameworks, cannabinoids have antinociceptive consequences. This is as per an enormous body of reassuring preclinical scientific proof.
Furthermore, it has been suggested that CBD may also address addiction by reducing the amygdala’s stimulation while transmitting unpleasant emotions. It has also been discovered to lessen heroin-seeking behavior, probably due to its serotonin and dopamine regulation. Cannabidiol is, therefore, a desirable option for treating chronic pain. Such is true mainly in the context of opiate addiction (Ishida et al.). Cannabidiol has potential efficacy, low potential for abuse, and favorable safety characteristics. CBD and hemp oils can come in handy to alleviate the issue of painkillers addiction. CBD and hemp oils have a reduced amount of THC. This means that it will provide patients with pain relief without them getting the ‘highness’ which instead leads to addiction.
Indications that CBD oils are better remedies for pain were prototype clinical studies with limited sample sizes. Therefore, more research is required. However, research shows potential future uses of cannabinoids in the therapeutic intervention of pain management and opioid addiction. In light of the contentious research supporting expanding access to medical cannabis as a pain relief alternative, more consideration should be given to the best commercial and political ways to expand access to CBD (Ishida et al.). That is why it is essential to legalize Marijuana to conduct more research and studies. Legalizing Marijuana means that more cannabis traits will be available for better inferences in the future. Notably, such studies may showcase other medicinal benefits of CBD oil besides pain relief.
Individuals recently started to notice a new assortment of products in their clinical spotlight. Due to extensive media coverage and the latest decriminalization of cannabis-based prescribed drugs, cannabidiol (CBD) oil has rapidly risen in the UK (Lall 395). When used topically, CBD oil is touted as a divine intervention treatment for conditions like attention deficit hyperactivity disorder (ADHD), cancer, epilepsy, various forms of sclerosis, neurodegenerative disorders, autism, and chronic inflammation and pain (Lall 395). A small body of research supports these claims, most focusing on CBD products obtained through prescribed medication.
Products constituting CBD oil are frequently marketed as natural self-medication and purchased as food supplements. Patients may be tempted by this, which is reasonable given that it gives them more control of their health (Lall 395). However, it could also result in more false diagnoses. More kinds of toothpaste drops and mouth sprays made from CBD oil are starting to appear. Additionally, these items are advertised as having the capacity to ease anxiety. For dental practitioners, there could be a lot of adverse effects from this. It is unknown what effects CBD-based items might have on the mouth.
Additionally, sedative/anxiolytic products may influence shared decision-making. Also, there may be unknown drug interactions. Considering the extent to which CBD oils are being sold without a guideline, it is sure to say that the same is happening in the United States. This calls for the quick decriminalization of Marijuana to ensure that nobody gets the wrong prescription for CBD oil products. Notably, most individuals purchasing these products are patients with chronic illnesses. Legalizing Marijuana will promote a more statute study of the products to ensure that patients are well informed before buying CBD oil products. The following picture shows marijuana leaves, seeds, and extracted CBD oil which, according to studies, is responsible for its medicinal benefits.
Conclusion
Hemp oils and cannabidiol are phytocannabinoid compounds that have potential benefits since they are not intoxicating. More study is required to comprehend better the clinical effectiveness and likely health impact of hemp oils CBD. This understanding is critical given the rising patient intrigue in and using these commodities. Although the items have not received FDA approval for medicinal use, caregivers continue to use them. Physicians should educate themselves about both significant safety concerns and possible therapeutic gain. Careful product selection is essential when considering patient safety and possible efficacy. Therefore, decriminalization of Marijuana is highly appropriate if scientists are to understand better the effects and benefits of CBD products and hemp oils. Additionally, the current product knowledge gap means patients purchase items without full knowledge of the appropriate quality or dosage.
Works Cited:
Cbd Oil Extraction Photos. “Free Photo | Cbd Oil Dropper Assortment.” Freepik, Web.
Hall, Wayne. “The Costs and Benefits of Cannabis Control Policies.” Cannabinoids, vol. 22, no. 3, Sept. 2020, pp. 281–87,
Ishida, Julie H., et al. “Substitution of Marijuana for Opioids in a National Survey of US Adults.” PLOS ONE, edited by Lars-Peter Kamolz, vol. 14, no. 10, 2019, p. e0222577.
Lall, S. “CBD Oil.” British Dental Journal, vol. 228, no. 6, 2020, pp. 395–95.
Marcu, Jahan. “The Legalization of Cannabinoid Products and Standardizing Cannabis-Drug Development in the United States: A Brief Report.” Cannabinoids, vol. 22, no. 3, 2020, pp. 289–93.
McGinty, Emma E., et al. “Public Perceptions of Arguments Supporting and Opposing Recreational Marijuana Legalization.” Preventive Medicine, vol. 99, 2017, pp. 80–86.
VanDolah, Harrison J., et al. “Clinicians’ Guide to Cannabidiol and Hemp Oils.” Mayo Clinic Proceedings, vol. 94, no. 9, 2019, pp. 1840–51.